Bio-Path Holdings (BPTH) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BPTH Bio-Path Holdings

Watchlist

1.190
+0.339+39.79%

Close Oct 8 16:00 ET

1.140
-0.050-4.20%

Post 19:59 ET

3.04MMarket Cap-83P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Bio-Path Has Initiated A Therapeutic Program To Develop BP1001-A For Obesity And Related Metabolic Diseases, This Program Marks The First Application Of DNAbilize Technology For Development Of A Non-cancer Application
BenzingaOct 8 07:08 ET
Express News | Bio-Path Holdings Announces $4.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules
Reuters20:00 ET
Press Release: Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Dow Jones20:00 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga12:30 ET
Crude Oil Falls Over 4%; US Trade Deficit Narrows In August
Benzinga12:16 ET
US Stocks Edge Higher; PepsiCo Cuts 2024 Revenue Outlook
BenzingaOct 8 09:51 ET

Comments

Jaguar8

4 hours ago

NEWS

$Bio-Path Holdings (BPTH.US)$
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Bio-Path Holdings (NASDAQ:BPTH) has announced a $4.0 million private placement priced at-the-market under Nasdaq rules. The company will issue and sell 4,597,702 shares of common stock (or equivalents), along with series A and B warrants to purchase additional shares. The purchase price is set at $0.87 per share, with warrants exercisable at $1.00 per share. The off...